106 related articles for article (PubMed ID: 15459403)
21. Diagnosis and management costs of suspicious skin lesions from a population-based melanoma screening programme.
Gordon L; Youl PH; Elwood M; Janda M; Ring IT; Lowe JB; Aitken JF
J Med Screen; 2007; 14(2):98-102. PubMed ID: 17626710
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
23. The Philadelphia High-School STD Screening Program: key insights from dynamic transmission modeling.
Fisman DN; Spain CV; Salmon ME; Goldberg M
Sex Transm Dis; 2008 Nov; 35(11 Suppl):S61-5. PubMed ID: 18607306
[TBL] [Abstract][Full Text] [Related]
24. The cost-effectiveness of cervical screening in Australia: what is the impact of screening at different intervals or over a different age range?
Anderson R; Haas M; Shanahan M
Aust N Z J Public Health; 2008 Feb; 32(1):43-52. PubMed ID: 18290913
[TBL] [Abstract][Full Text] [Related]
25. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
26. Economic evaluation of HIV screening in pregnant women attending antenatal clinics in India.
Kumar M; Birch S; Maturana A; Gafni A
Health Policy; 2006 Jul; 77(2):233-43. PubMed ID: 16126300
[TBL] [Abstract][Full Text] [Related]
27. Costs and cost effectiveness of different strategies for chlamydia screening and partner notification: an economic and mathematical modelling study.
Turner K; Adams E; Grant A; Macleod J; Bell G; Clarke J; Horner P
BMJ; 2011 Jan; 342():c7250. PubMed ID: 21205807
[TBL] [Abstract][Full Text] [Related]
28. Collecting direct non-health care and time cost data: application to screening and diagnosis of cervical cancer.
Cantor SB; Levy LB; Cárdenas-Turanzas M; Basen-Engquist K; Le T; Beck JR; Follen M
Med Decis Making; 2006; 26(3):265-72. PubMed ID: 16751325
[TBL] [Abstract][Full Text] [Related]
29. Cost and effectiveness of Chlamydia screening among male military recruits: Markov modeling of complications averted through notification of prior female partners.
Nevin RL; Shuping EE; Frick KD; Gaydos JC; Gaydos CA
Sex Transm Dis; 2008 Aug; 35(8):705-13. PubMed ID: 18461015
[TBL] [Abstract][Full Text] [Related]
30. Gonorrhea and chlamydia screening in sexually active young women: the processes of change.
Chacko MR; Von Sternberg K; Velasquez MM
J Adolesc Health; 2004 May; 34(5):424-7. PubMed ID: 15093798
[TBL] [Abstract][Full Text] [Related]
31. Screening for Chlamydia trachomatis: a systematic review of the economic evaluations and modelling.
Roberts TE; Robinson S; Barton P; Bryan S; Low N;
Sex Transm Infect; 2006 Jun; 82(3):193-200; discussion 201. PubMed ID: 16731666
[TBL] [Abstract][Full Text] [Related]
32. High cost of Chlamydia can be cut, researcher finds.
Silversides A
CMAJ; 1999 Apr; 160(8):1119. PubMed ID: 10234330
[No Abstract] [Full Text] [Related]
33. Cost-utility of repeated screening for Chlamydia trachomatis.
de Vries R; van Bergen JE; de Jong-van den Berg LT; Postma MJ;
Value Health; 2008; 11(2):272-4. PubMed ID: 18380639
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of five strategies for gonorrhea and chlamydia control among female and male emergency department patients.
Mehta SD; Bishai D; Howell MR; Rothman RE; Quinn TC; Zenilman JM
Sex Transm Dis; 2002 Feb; 29(2):83-91. PubMed ID: 11818893
[TBL] [Abstract][Full Text] [Related]
35. Increasing the uptake of opportunistic chlamydia screening: a pilot study in general practice.
Lawton BA; Rose SB; Elley CR; Bromhead C; MacDonald EJ; Baker MG
J Prim Health Care; 2010 Sep; 2(3):199-207. PubMed ID: 21069115
[TBL] [Abstract][Full Text] [Related]
36. Screening for Chlamydia trachomatis in adolescent males: a cost-based decision analysis.
Randolph AG; Washington AE
Am J Public Health; 1990 May; 80(5):545-50. PubMed ID: 2109544
[TBL] [Abstract][Full Text] [Related]
37. Large increase in opportunistic testing for chlamydia during a pilot project in a primary health organisation.
Azariah S; McKernon S; Werder S
J Prim Health Care; 2013 Jun; 5(2):141-5. PubMed ID: 23748396
[TBL] [Abstract][Full Text] [Related]
38. Economic evaluation of the cost of different methods of retesting chlamydia positive individuals in England.
Looker KJ; Buitendam E; Woodhall SC; Hollis E; Ong KJ; Saunders JM; Dunbar K; Turner KME
BMJ Open; 2019 Mar; 9(3):e024828. PubMed ID: 30904855
[TBL] [Abstract][Full Text] [Related]
39. Costs and effects of chlamydial screening: dynamic versus static modeling.
Welte R; Postma M; Leidl R; Kretzschmar M
Sex Transm Dis; 2005 Aug; 32(8):474-83. PubMed ID: 16041248
[TBL] [Abstract][Full Text] [Related]
40. The cost of implementing a 2-1-1 call center-based cancer control navigator program.
Lairson DR; Huo J; Ricks KA; Savas L; Fernández ME
Eval Program Plann; 2013 Aug; 39():51-6. PubMed ID: 23669647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
